DK681688A - Pyrimidonforbindelser og farmaceutisk acceptable salte heraf - Google Patents
Pyrimidonforbindelser og farmaceutisk acceptable salte herafInfo
- Publication number
- DK681688A DK681688A DK681688A DK681688A DK681688A DK 681688 A DK681688 A DK 681688A DK 681688 A DK681688 A DK 681688A DK 681688 A DK681688 A DK 681688A DK 681688 A DK681688 A DK 681688A
- Authority
- DK
- Denmark
- Prior art keywords
- pyrimidone
- pyrimidon
- compounds
- acceptable salts
- gastric
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title abstract 4
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 230000027119 gastric acid secretion Effects 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 241001024304 Mino Species 0.000 abstract 1
- 208000025865 Ulcer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000001079 digestive effect Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 230000002633 protecting effect Effects 0.000 abstract 1
- -1 pyrimidone compound Chemical class 0.000 abstract 1
- 208000018556 stomach disease Diseases 0.000 abstract 1
- 231100000397 ulcer Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30929387 | 1987-12-07 | ||
| JP62309293A JPH0613486B2 (ja) | 1987-12-07 | 1987-12-07 | ピリミドン誘導体及びその医薬的に許容される塩 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK681688D0 DK681688D0 (da) | 1988-12-07 |
| DK681688A true DK681688A (da) | 1989-06-08 |
| DK169323B1 DK169323B1 (da) | 1994-10-10 |
Family
ID=17991256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK681688A DK169323B1 (da) | 1987-12-07 | 1988-12-07 | Pyrimidonforbindelser og farmaceutisk acceptable salte heraf |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4956463A (da) |
| EP (1) | EP0319903B1 (da) |
| JP (1) | JPH0613486B2 (da) |
| KR (1) | KR960002557B1 (da) |
| AT (1) | ATE110060T1 (da) |
| AU (1) | AU609229B2 (da) |
| CA (1) | CA1308717C (da) |
| DE (1) | DE3851129T2 (da) |
| DK (1) | DK169323B1 (da) |
| ES (1) | ES2058223T3 (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS597177A (ja) * | 1982-07-06 | 1984-01-14 | Teikoku Hormone Mfg Co Ltd | 新規な置換ベンジルアミン誘導体 |
| JO1275B1 (en) * | 1982-12-03 | 1985-04-20 | هنري براون ثوماس | Chemical process |
| JPS60255756A (ja) * | 1984-06-01 | 1985-12-17 | Ikeda Mohandou:Kk | アミノアルキルフエノキシ誘導体 |
| CA1275097A (en) * | 1984-10-02 | 1990-10-09 | Fujio Nohara | Pyridyloxy derivatives |
| JPS61155373A (ja) * | 1984-12-28 | 1986-07-15 | Yamanouchi Pharmaceut Co Ltd | 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法 |
-
1987
- 1987-12-07 JP JP62309293A patent/JPH0613486B2/ja not_active Expired - Lifetime
-
1988
- 1988-12-05 KR KR1019880016181A patent/KR960002557B1/ko not_active Expired - Fee Related
- 1988-12-06 AU AU26563/88A patent/AU609229B2/en not_active Ceased
- 1988-12-06 ES ES88120340T patent/ES2058223T3/es not_active Expired - Lifetime
- 1988-12-06 CA CA000585089A patent/CA1308717C/en not_active Expired - Fee Related
- 1988-12-06 EP EP88120340A patent/EP0319903B1/en not_active Expired - Lifetime
- 1988-12-06 AT AT88120340T patent/ATE110060T1/de not_active IP Right Cessation
- 1988-12-06 DE DE3851129T patent/DE3851129T2/de not_active Expired - Fee Related
- 1988-12-07 US US07/281,040 patent/US4956463A/en not_active Expired - Fee Related
- 1988-12-07 DK DK681688A patent/DK169323B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0319903B1 (en) | 1994-08-17 |
| EP0319903A3 (en) | 1990-07-25 |
| DK681688D0 (da) | 1988-12-07 |
| DK169323B1 (da) | 1994-10-10 |
| AU609229B2 (en) | 1991-04-26 |
| US4956463A (en) | 1990-09-11 |
| JPH0613486B2 (ja) | 1994-02-23 |
| AU2656388A (en) | 1989-06-08 |
| ES2058223T3 (es) | 1994-11-01 |
| KR960002557B1 (ko) | 1996-02-22 |
| JPH01149774A (ja) | 1989-06-12 |
| DE3851129T2 (de) | 1994-12-01 |
| EP0319903A2 (en) | 1989-06-14 |
| KR890009889A (ko) | 1989-08-04 |
| ATE110060T1 (de) | 1994-09-15 |
| CA1308717C (en) | 1992-10-13 |
| DE3851129D1 (de) | 1994-09-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9301830D0 (sv) | New compounds | |
| EP0285008A3 (en) | The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse | |
| ZA893086B (en) | 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial disease | |
| DK102788D0 (da) | Quinolinforbindelse og dens farmaceutiske anvendelse | |
| DK681688D0 (da) | Pyrimidonforbindelser og farmaceutisk acceptable salte heraf | |
| DE69419954D1 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
| HUT48464A (en) | Process for producing pharmaceutical composition for treating hypertonia and cardiac failure | |
| EP0383481A3 (en) | Anesthetic oral compositions | |
| NO180085C (no) | Acylsulfonamido- og sulfonamidopyridin-2-karboksylsyreestere og deres anvendelse som legemidler | |
| PT82847A (de) | "4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaure-(n-(3-trifluormethyl-phenyl)-amide)zur antithrombotischen prophylaxe und behanbdlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln | |
| GR852408B (da) | ||
| NO881798D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
| EP0227339A3 (en) | Xamoterol for the treatment of obesity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |